TNNC1 Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P63316 |
---|---|
Clone Names | 100427210 |
Gene ID | 7134 |
---|---|
Other Names | Troponin C, slow skeletal and cardiac muscles, TN-C, TNNC1, TNNC |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP13841a was selected from the N-term region of TNNC1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | TNNC1 |
---|---|
Synonyms | TNNC |
Function | Troponin is the central regulatory protein of striated muscle contraction. Tn consists of three components: Tn-I which is the inhibitor of actomyosin ATPase, Tn-T which contains the binding site for tropomyosin and Tn-C. The binding of calcium to Tn-C abolishes the inhibitory action of Tn on actin filaments. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Troponin is a central regulatory protein of striatedmuscle contraction, and together with tropomyosin, is located onthe actin filament. Troponin consists of 3 subunits: TnI, which isthe inhibitor of actomyosin ATPase; TnT, which contains the bindingsite for tropomyosin; and TnC, the protein encoded by this gene.The binding of calcium to TnC abolishes the inhibitory action ofTnI, thus allowing the interaction of actin with myosin, thehydrolysis of ATP, and the generation of tension. Mutations in thisgene are associated with cardiomyopathy dilated type 1Z. [providedby RefSeq].
References
Parvatiyar, M.S., et al. J. Biol. Chem. 285(36):27785-27797(2010)Swindle, N., et al. Biochemistry 49(23):4813-4820(2010)Dweck, D., et al. J. Biol. Chem. 285(23):17371-17379(2010)Bates, K.J., et al. Clin. Chem. 56(6):952-958(2010)Hershberger, R.E., et al. Circ Cardiovasc Genet 3(2):155-161(2010)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.